DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "MediPoint: Elbow Replacement - Global Analysis and Market Forecasts" report to their offering.
It is estimated that sales of elbow replacement implants to be approximately US$47.1M globally in 2016. The market is expected to grow at a CAGR of 3.2% over the forecast period, reaching sales of US$58.8M by 2023.
The accelerators for growth in the elbow replacement market include changing population demographics, physical activity levels associated with the older generation, and an increased awareness of the procedure. Compared to past years, people tend to engage in competitive sports and other intense physical activities from an earlier age and until later in life.
Total elbow arthroplasty (TEA) is one of the five procedures that make up the extremity joint market; the others are shoulder, wrist, digit, and ankle. As the general population ages, the number of arthritis cases and elbow fractures increase, contributing largely to the number of elbow replacements performed. Although arthritis in small joints occurs far less frequently than at the hip or knee joint, the physical impairments for patients with extremity arthritis are equivalent to those of other forms of arthritis. The disability of these joints can severely hinder a person's ability to engage in recreational activities, perform vocational duties, or even carry out the activities of daily living.
Key drivers of the elbow replacement market in the forecast period are:
- The growing global aging population and rising prevalence of diseases such as osteoarthritis (OA) and rheumatoid arthritis (RA).
- Patient preference for an active lifestyle, leading to the choice of total joint replacement over joint fusion.
- Continued efforts from manufacturers to promote and educate patients and surgeons about extremity implants.
Europe, South America and Middle East and Africa elbow replacement market is projected to grow at a CAGR of 4.5% in the forecast period, followed by North America and APAC at 3.6% and 3.8% respectively.
Most of the elbow replacement market is occupied by a few players including Wright Medical, Stryker, Zimmer Biomet, and Integra LifeSciences. These companies are dominant players in the medical device industry with significant clinical research data driving product adoption and expansive sales and distribution networks.
Key Topics Covered:
1 Table of Contents
2 Executive Summary
4 Market Outlook
5 Market Insights
6 Competitive Assessment
- Corin Group
- DJO Global
- Integra LifeSciences
- Kyocera Medical
- Lima Corporate
- Wright Medical Group
- Zimmer Biomet
For more information about this report visit https://www.researchandmarkets.com/research/9hqlw2/medipoint_elbow